---
search:
  boost: 2 
---

# Ophthalmic Steroids

This is a subcategory of Ophthalmic Agents.

## Decision Trees

- [Ophthalmic Steroids - Difluprednate*, Inveltys, Lotemax SM, Loteprednol*](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUOVlWQkg1N0EzVEw1MjJNQlVYS0pZWEVHQiQlQCN0PWcu&topview=Preview){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                      | Generic Name | Quantity | Time (Days) |
|:-------------------------------|:-------------|:--------:|:-----------:|
| Alrex <sup>BvG</sup>           |              |          |             |
| Dexamethasone Sodium Phosphate |              |          |             |
| Durezol <sup>BvG</sup>         |              |          |             |
| Flarex                         |              |          |             |
| Fluorometholone                |              |          |             |
| Fml Forte                      |              |          |             |
| Fml S.O.P.                     |              |          |             |
| Lotemax <sup>BvG</sup>         |              |          |             |
| Maxidex                        |              |          |             |
| Pred Forte                     |              |          |             |
| Pred Mild                      |              |          |             |
| Prednisolone Acetate           |              |          |             |
| Prednisolone Sodium Phosphate  |              |          |             |

### Non-Preferred

| Non-Preferred | Generic Name | Quantity | Time (Days) |
|:--------------|:-------------|:--------:|:-----------:|
| Difluprednate |              |          |             |
| Inveltys      |              |          |             |
| Lotemax SM    |              |          |             |
| Loteprednol   |              |          |             |

## Authorizations

**Length of Authorizations**: 30 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria 

### Non-Preferred

**Non-Preferred Criteria**

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **14 days** with at least **two preferred** drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_Criteria%20_APPROVED.pdf#page=90){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_v7_Approved.pdf#page=29){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
